272 related articles for article (PubMed ID: 22491916)
1. Intravitreal ketorolac for chronic uveitis and macular edema: a pilot study.
Kim SJ; Doherty TJ; Cherney EF
Arch Ophthalmol; 2012 Apr; 130(4):456-60. PubMed ID: 22491916
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal injection of commercially available ketorolac tromethamine in eyes with diabetic macular edema refractory to laser photocoagulation.
Maldonado RM; Vianna RN; Cardoso GP; de Magalhães AV; Burnier MN
Curr Eye Res; 2011 Aug; 36(8):768-73. PubMed ID: 21780926
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study.
Mackensen F; Heinz C; Becker MD; Heiligenhaus A
Retina; 2008 Jan; 28(1):41-5. PubMed ID: 18185136
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
5. Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies.
Soheilian M; Karimi S; Ramezani A; Peyman GA
Retina; 2010 Mar; 30(3):509-15. PubMed ID: 19952986
[TBL] [Abstract][Full Text] [Related]
6. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
[TBL] [Abstract][Full Text] [Related]
7. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion.
Pai SA; Shetty R; Vijayan PB; Venkatasubramaniam G; Yadav NK; Shetty BK; Babu RB; Narayana KM
Am J Ophthalmol; 2007 Apr; 143(4):601-6. PubMed ID: 17306753
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
9. intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group.
Wu L; Hernandez-Bogantes E; Roca JA; Arevalo JF; Barraza K; Lasave AF
Retina; 2011 Feb; 31(2):298-303. PubMed ID: 21099452
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab for treatment of uveitic macular edema.
Cordero Coma M; Sobrin L; Onal S; Christen W; Foster CS
Ophthalmology; 2007 Aug; 114(8):1574-1579.e1. PubMed ID: 17363060
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind, placebo-controlled clinical trial on the efficacy of 0.5% indomethacin eye drops in uveitic macular edema.
Allegri P; Murialdo U; Peri S; Carniglia R; Crivelli MG; Compiano S; Autuori S; Mastromarino A; Zurria M; Marrazzo G
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1463-70. PubMed ID: 24519421
[TBL] [Abstract][Full Text] [Related]
13. Adverse events after intravitreal infliximab (Remicade).
Giganti M; Beer PM; Lemanski N; Hartman C; Schartman J; Falk N
Retina; 2010 Jan; 30(1):71-80. PubMed ID: 19996827
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema.
Rauen PI; Ribeiro JA; Almeida FP; Scott IU; Messias A; Jorge R
Retina; 2012 Oct; 32(9):1799-803. PubMed ID: 22495327
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema.
Soheilian M; Eskandari A; Ramezani A; Rabbanikhah Z; Soheilian R
Ocul Immunol Inflamm; 2013 Apr; 21(2):124-9. PubMed ID: 23697857
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of an intravitreal dexamethasone implant for the treatment of noninfectious uveitic macular edema.
Habot-Wilner Z; Sorkin N; Goldenberg D; Loewenstein A; Goldstein M
Ophthalmologica; 2014; 232(2):77-82. PubMed ID: 25012541
[TBL] [Abstract][Full Text] [Related]
19. Ranibizumab for refractory uveitis-related macular edema.
Acharya NR; Hong KC; Lee SM
Am J Ophthalmol; 2009 Aug; 148(2):303-309.e2. PubMed ID: 19427988
[TBL] [Abstract][Full Text] [Related]
20. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction.
Weisz JM; Bressler NM; Bressler SB; Schachat AP
Ophthalmology; 1999 Sep; 106(9):1656-9. PubMed ID: 10485530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]